Alnylam Pharmace. buy RudolfL
Start price
10.01.21
/
0%
€120.44
Target price
10.01.22
-
Performance (%)
19.23%
End price
27.12.21
€143.60
Summary
This prediction ended on 27.12.21 with a price of €143.60. The prediction had a final performance of 19.23%. This prediction was marked as speculative and is excluded from RudolfL's performance statistics.Alnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -3.833% | -3.833% | 27.755% | 45.037% |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% | 63.672% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% | 109.562% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% | 54.912% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% | 69.801% |
Comments by RudolfL for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.
In the thread Trading Alnylam Pharmace.
Stopped prediction by RudolfL for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€88.35
19.11.19
19.11.19
€140.00
04.11.21
04.11.21
15.29%
10.12.20
10.12.20
